The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
The endocannabinoid system: a general view and latest additions
Open accessAbstract
After the discovery, in the early 1990s, of specific G‐protein‐coupled receptors for marijuana's psychoactive principle Δ 9‐tetrahydrocannabinol, the cannabinoid receptors, and of their endogenous agonists, the endocannabinoids, a decade of investigations has greatly enlarged our understanding of this altogether new signalling system. Yet, while the finding of the endocannabinoids resulted in a new effort to reveal the mechanisms regulating their levels in the brain and peripheral organs under physiological and pathological conditions, more endogenous substances with a similar action, and more molecular targets for the previously discovered endogenous ligands, anandamide and 2‐arachidonoylglycerol, or for some of their metabolites, were being proposed. As the scenario becomes subsequently more complicated, and the experimental tasks to be accomplished correspondingly more numerous, we briefly review in this article the latest ‘additions’ to the endocannabinoid system together with earlier breakthroughs that have contributed to our present knowledge of the biochemistry and pharmacology of the endocannabinoids. British Journal of Pharmacology (2004) 141, 765–774. doi:10.1038/sj.bjp.0705666
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142 · cited 1×
“…(Chemin et al., 2001) are blocked by AEA, whereas vanilloid type 1 (VR1, also known as TRPV1) receptors, the sites of action of the pungent component of ‘hot’ red peppers, capsaicin (Szallasi & Blumberg, 1999), are activated by this endocannabinoid (Zygmunt et al., 1999; Smart et al., 2000).”
BackgroundMolecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Vanilloid (Capsaicin) Receptors and Mechanisms
Szallasi, A., & Blumberg, P. M. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01403-0 · Cited by 1,903
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 2×
“As previously found for FAAH (Egertova et al., 1998), rat MAGL is expressed in brain regions with high cannabinoid CB1 receptor density, such as the hippocampus, but, unlike FAAH, it occurs in presynaptic neurons and is likely to be coexpressed with CB1 receptors (Dinh et al., 2002).”
BackgroundBisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
Self-citationHuang, S. M., Bisogno, T., Trevisani, M., Al-Hayani, A., De Petrocellis, L., Fezza, F., Tognetto, M., Petros, T. J., Krey, J. F., Chu, C. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122196999 · Cited by 964
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., & Davis, J. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703050 · Cited by 775
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
Hanuš, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 762
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
Heterosynaptic LTD of Hippocampal GABAergic Synapses
Chevaleyre, V., & Castillo, P. E. (2003) · Neuron · doi:10.1016/s0896-6273(03)00235-6 · Cited by 655
Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M.-H., Vogel, Z., Bisogno, T., De Petrocellis, L., Di Marzo, V., & Mechoulam, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00392-6 · Cited by 629
Porter, A. C., Sauer, J.-M., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J., Nomikos, G. G., Carter, P., Bymaster, F. P., Leese, A. B., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1020 · Cited by 615
Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. R., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 599
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Breivogel, C. S., Griffin, G., Di Marzo, V., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 541
Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling
Bracey, M. H., Hanson, M. A., Masuda, K. R., Stevens, R. C., & Cravatt, B. F. (2002) · Science · doi:10.1126/science.1076535 · Cited by 490
cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase
Karlsson, M., Contreras, J. A., Hellman, U., Tornqvist, H., & Holm, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27218 · Cited by 422
Cadas, H., di Tomaso, E., & Piomelli, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01226.1997 · Cited by 396
BISOGNO, T., MELCK, D., BOBROV, M. Y., GRETSKAYA, N. M., BEZUGLOV, V. V., De PETROCELLIS, L., & Di MARZO, V. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510817 · Cited by 381
Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes
Bisogno, T., Maurelli, S., Melck, D., De Petrocellis, L., & Di Marzo, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3315 · Cited by 369
De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agrò, A., & Di Marzo, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008555200 · Cited by 355
Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0356 · Cited by 348
De Petrocellis, L., Bisogno, T., Davis, J. B., Pertwee, R. G., & Di Marzo, V. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02082-2 · Cited by 347
Huang, S. M., Bisogno, T., Petros, T. J., Chang, S. Y., Zavitsanos, P. A., Zipkin, R. E., Sivakumar, R., Coop, A., Maeda, D. Y., De Petrocellis, L., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107351200 · Cited by 339
Hillard, C. J., Edgemond, W. S., Jarrahian, A., & Campbell, W. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020631.x · Cited by 338
Egertová, M., Giang, D. K., Cravatt, B. F., & Elphick, M. R. (1998) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1998.0543 · Cited by 334
The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1
Maingret, F. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.47 · Cited by 313
Bisogno, T., Berrendero, F., Ambrosino, G., Cebeira, M., Ramos, J. A., Fernandez-Ruiz, J. J., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0254 · Cited by 312
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
Cravatt, B. F., & Lichtman, A. H. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00079-6 · Cited by 302
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide
Chemin, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7033 · Cited by 299
Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296
Berrendero, F., Sepe, N., Ramos, J. A., Di Marzo, V., & Fern�ndez-Ruiz, J. J. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990901)33:3<181::aid-syn3>3.0.co;2-r · Cited by 289
Evidence against the presence of an anandamide transporter
Glaser, S. T., Abumrad, N. A., Fatade, F., Kaczocha, M., Studholme, K. M., & Deutsch, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730816100 · Cited by 279
BISOGNO, T., SEPE, N., MELCK, D., MAURELLI, S., PETROCELLIS, L. D., & MARZO, V. D. (1997) · Biochemical Journal · doi:10.1042/bj3220671 · Cited by 275
Self-citationEndovanilloid signaling in pain
Di Marzo, V (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00340-9 · Cited by 273
The fatty acid amide hydrolase (FAAH)
Ueda, N., Puffenbarger, R. A., Yamamoto, S., & Deutsch, D. G. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00190-0 · Cited by 256
Di Marzo, V., De Petrocellis, L., Fezza, F., Ligresti, A., & Bisogno, T. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0349 · Cited by 242
The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response
Williams, E.-J., Walsh, F. S., & Doherty, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200210164 · Cited by 230
Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor
Offertáler, L., Mo, F.-M., Bátkai, S., Liu, J., Begg, M., Razdan, R. K., Martin, B. R., Bukoski, R. D., & Kunos, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.699 · Cited by 228
Lichtman, A. H., Hawkins, E. G., Griffin, G., & Cravatt, B. F. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.73 · Cited by 227
Di Marzo, V., Bisogno, T., & De Petrocellis, L. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01712-0 · Cited by 225
The Pharmacology of Bimatoprost (Lumigan™)
Woodward, D. F., Krauss, A. H.-P., Chen, J., Lai, R. K., Spada, C. S., Burk, R. M., Andrews, S. W., Shi, L., Liang, Y., Kedzie, K. M., et al. (2001) · Survey of Ophthalmology · doi:10.1016/s0039-6257(01)00224-7 · Cited by 215
Goparaju, S., Ueda, N., Taniguchi, K., & Yamamoto, S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00314-1 · Cited by 213
Sugiura, T., Kondo, S., Sukagawa, A., Tonegawa, T., Nakane, S., Yamashita, A., Ishima, Y., & Waku, K. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0053h.x · Cited by 211
The fatty acid amide hydrolase (FAAH)
Deutsch, D. G., Ueda, N., & Yamamoto, S. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0358 · Cited by 210
Cellular accumulation of anandamide: consensus and controversy
Hillard, C. J., & Jarrahian, A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705468 · Cited by 203
Hájos, N., & Freund, T. F. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00157-0 · Cited by 202
MARZO, V. D., BISOGNO, T., SUGIURA, T., MELCK, D., & PETROCELLIS, L. D. (1998) · Biochemical Journal · doi:10.1042/bj3310015 · Cited by 199
Self-citationAnandamide Hydrolysis by Human Cells in Culture and Brain
Maccarrone, M., van der Stelt, M., Rossi, A., Veldink, G. A., Vliegenthart, J. F. G., & Agrò, A. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32332 · Cited by 197
Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide
Maccarrone, M., Bari, M., Lorenzon, T., Bisogno, T., Di Marzo, V., & Finazzi-Agrò, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13484 · Cited by 184
Ahluwalia, J., Urban, L., Bevan, S., & Nagy, I. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02703.x · Cited by 183
Oxidative metabolism of endocannabinoids
Kozak, K. R., & Marnett, L. J. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0359 · Cited by 170
van der Stelt, M., van Kuik, J. A., Bari, M., van Zadelhoff, G., Leeflang, B. R., Veldink, G. A., Finazzi‐Agrò, A., Vliegenthart, J. F. G., & Maccarrone, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020818q · Cited by 168
Bisogno, T., Melck, D., De Petrocellis, L., & Di Marzo, V. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722113.x · Cited by 162
Maccarrone, M., De Petrocellis, L., Bari, M., Fezza, F., Salvati, S., Di Marzo, V., & Finazzi-Agrò, A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2500 · Cited by 162
Guzmán, M., Sánchez, C., & Galve-Roperh, I. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00256-5 · Cited by 161
15-Lipoxygenase Metabolism of 2-Arachidonylglycerol
Kozak, K. R., Gupta, R. A., Moody, J. S., Ji, C., Boeglin, W. E., DuBois, R. N., Brash, A. R., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201084200 · Cited by 160
The N-acylation-phosphodiesterase pathway and cell signalling
Schmid, H. H. O., Schmid, P. C., & Natarajan, V. (1996) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(96)02554-6 · Cited by 159
Dual effect of cannabinoid CB 1 receptor stimulation on a vanilloid VR1 receptor-mediated response
Hermann, H., PETROCELLIS, L. D., Bisogno, T., Moriello, A. S., Lutz, B., & Marzo, V. D. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s000180300052 · Cited by 153
Self-citationNovel selective and metabolically stable inhibitors of anandamide cellular uptake
Ortar, G., Ligresti, A., PETROCELLIS, L. D., Morera, E., & Marzo, V. D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00109-6 · Cited by 148
Self-citationMetabolism of Prostaglandin Glycerol Esters and Prostaglandin Ethanolamides in Vitro and in Vivo
Kozak, K. R., Crews, B. C., Ray, J. L., Tai, H., Morrow, J. D., & Marnett, L. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105854200 · Cited by 139
Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Brandi, I., Jefferson, R. G., Winckler, R., Davis, J. B., DASSE, O. A., Mahadevan, A., Razdan, R. K., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4354 · Cited by 138
Self-citationEndocannabinoids Induce Ileitis in Rats via the Capsaicin Receptor (VR1)
McVey, D. C., Schmid, P. C., Schmid, H. H. O., & Vigna, S. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043893 · Cited by 136
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues
Marzo, V. D., Lastres‐Becker, I., Bisogno, T., PETROCELLIS, L. D., Milone, A., Davis, J. B., & Fernández‐Ruíz, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01012-3 · Cited by 132
Self-citationRoss, R. A., Craib, S. J., Stevenson, L., Pertwee, R. G., Henderson, A., Toole, J. J., & Ellington, H. C. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.900 · Cited by 128
Fezza, F., Bisogno, T., Minassi, A., Appendino, G., Mechoulam, R., & Marzo, V. D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02341-4 · Cited by 127
Self-citationEdgemond, W. S., Hillard, C. J., Falck, J. R., Kearn, C. S., & Campbell, W. B. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.180 · Cited by 116
Basavarajappa, B. S., Saito, M., Cooper, T. B., & Hungund, B. L. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01557-7 · Cited by 115
Kempe, K. C., Hsu, F., Bohrer, A., & TURK, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17287 · Cited by 114
Maccarrone, M., Bari, M., Rienzo, M. D., Finazzi‐Agrò, A., & Rossi, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302123200 · Cited by 113
Marzo, V. D., PETROCELLIS, L. D., Sugiura, T., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1501 · Cited by 110
Self-citationTranscriptional regulation of the mouse fatty acid amide hydrolase gene
Waleh, N. S., Cravatt, B. F., Apte-Deshpande, A. D., Terao, A., & Kilduff, T. S. (2002) · Gene · doi:10.1016/s0378-1119(02)00598-x · Cited by 104
A Structure/Activity Relationship Study on Arvanil, an Endocannabinoid and Vanilloid Hybrid
Marzo, V. D., Griffin, G., PETROCELLIS, L. D., Brandi, I., Bisogno, T., Williams, W., Grier, M. C., Kulasegram, S., Mahadevan, A., Razdan, R. K., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.984 · Cited by 97
Self-citationOka, S., Tsuchie, A., Tokumura, A., Muramatsu, M., Suhara, Y., Takayama, H., Waku, K., & Sugiura, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01804.x · Cited by 96
Craib, S. J., Ellington, H. C., Pertwee, R. G., & Ross, R. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704223 · Cited by 95
Sagan, S., Venance, L., Torrens, Y., Cordier, J., Glowinski, J., & Giaume, C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00480.x · Cited by 90
Berdyshev, E. V., Schmid, P. C., Krebsbach, R. J., & Schmid, H. H. O. (2001) · The FASEB Journal · doi:10.1096/fj.01-0181com · Cited by 90
Leptin Activates the Anandamide Hydrolase Promoter in Human T Lymphocytes through STAT3
Maccarrone, M., Rienzo, M. D., Finazzi‐Agrò, A., & Rossi, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211248200 · Cited by 87
N‐acylphosphatidylethanolamine‐hydrolysing phospholipase D lacks the ability to transphosphatidylate
Petersen, G. L., & Hansen, H. S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00861-3 · Cited by 78
Schmid, H. H. O., Schmid, P. C., & Berdyshev, E. V. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00157-3 · Cited by 78
CB1 cannabinoid receptor-G protein association: a possible mechanism for differential signaling
Mukhopadhyay, S., Shim, J., Assi, A.-A. A., Norford, D. C., & Howlett, A. C. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00153-6 · Cited by 75
Maccarrone, M., Fiorucci, L., Erba, F., Bari, M., Finazzi‐Agrò, A., & Ascoli, F. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01223-0 · Cited by 75
López-Rodríguez, M. L., Viso, A., Ortega‐Gutiérrez, S., Lastres‐Becker, I., González, S. R., Fernández‐Ruíz, J., & Ramos, J. A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm015545y · Cited by 71
Fowler, C. J., & Jacobsson, S. O. P. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0357 · Cited by 69
The endocannabinoid system in invertebrates
Salzet, M., & Stefano, G. B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0347 · Cited by 66
Sugiura, T., Yoshinaga, N., & Waku, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01691-8 · Cited by 63
Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebrates
McPartland, J. M., & Glass, M. (2003) · Gene · doi:10.1016/s0378-1119(03)00638-3 · Cited by 60
Ueda, N., Liu, Q., & Yamanaka, K. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00120-2 · Cited by 55
Activation of N-acylethanolamine-releasing phospholipase D by polyamines
Liu, Q., Tonai, T., & Ueda, N. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00015-4 · Cited by 43
Characterization of the 5′-sequence of the mouse fatty acid amide hydrolase
Puffenbarger, R. A., Kapulina, O., Howell, J. M., & Deutsch, D. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02274-1 · Cited by 21
Cited by
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,499
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Mammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Self-citation
Metadata
- Authors
- Petrocellis, L. D., Cascio, M. G., & Marzo, V. D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2004-03
- Volume
- 141
- Issue
- 5
- Pages
- 765-774
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2062867847
- Cited by
- 475
- References
- 100
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.